Long-term Safety and Efficacy of Deucravacitinib in Participants with Crohn's Disease or Ulcerative Colitis (IM011-077)
Completed
- Conditions
- Moderate to Severe Crohn's Disease or Moderate to Severe Ulcerative Colitis
- Registration Number
- jRCT2031210637
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Previously completed OLE treatment in 1 of the parent CD or UC studies
Exclusion Criteria
Any disease or medical condition that, in the opinion of the investigator, would make the participant unsuitable for this study, would interfere with the interpretation of participant safety or study results, or is considered unsuitable by the investigator for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- single assignment
- Primary Outcome Measures
Name Time Method - To assess the safety and tolerability of long-term use of BMS-986165(Deucravacitinib)
- Secondary Outcome Measures
Name Time Method